Patent details

EP2142185 Title: DROXIDOPA AND PHARMACEUTICAL COMPOSITION THEREOF FOR THE TREATMENT OF NEURALLY MEDIATED HYPOTENSION

Basic Information

Publication number:
EP2142185
PCT Application Number:
PCT/US/2008/056675
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP087320123
PCT Publication Number:
WO/2008/112773
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
DROXIDOPA AND PHARMACEUTICAL COMPOSITION THEREOF FOR THE TREATMENT OF NEURALLY MEDIATED HYPOTENSION
French Title of Invention:
DROXIDOPA ET COMPOSITION PHARMACEUTIQUE DE CELLE-CI POUR LE TRAITEMENT DE L'HYPOTENSION VÉHICULÉE PAR VOIE NEURALE
German Title of Invention:
DROXIDOPA UND PHARMAZEUTISCHE ZUSAMMENSETZUNG DAVON ZUR BEHANDLUNG VON NEURAL VERMITTELTER HYPERTONIE
SPC Number:

Dates

Filing date:
12/03/2008
Grant date:
15/08/2012
EP Publication Date:
15/08/2012
PCT Publication Date:
18/09/2008
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
13/01/2010
EP B1 Publication Date:
15/08/2012
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
12/03/2013
Expiration date:
12/03/2028
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
12/03/2008
 
 

Name:
Chelsea Therapeutics Inc.
Address:
3530 Toringdon Way Suite 200, Charlotte, NC 28277, United States (US)

Inventor

1

Name:
PEDDER Simon
Address:
United States (US)

2

Name:
ROBERTS Michael, J.
Address:
United States (US)

Priority

Priority Number:
894354 P
Priority Date:
12/03/2007
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/15;
Filing date Document type Number of pages